Millennium Management’s NeuroDerm Ltd. Ordinary Shares NDRM Stock Holding History

Millennium Management’s Portfolio NDRM Stock Details NDRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-15,000	Closed	-$584K	–	4348
2017 Q3	$584K	Sell	15,000 -5,731	-28%	-$211K	﹤0.01%	2773
2017 Q2	$620K	Sell	20,731 -243,840	-92%	-$6.32M	﹤0.01%	2701
2017 Q1	$7.02M	Sell	264,571 -155,728	-37%	-$3.86M	0.01%	1244
2016 Q4	$9.33M	Buy	+420,299	New	+$7.86M	0.02%	965
2015 Q4	–	Sell	-96,192	Closed	-$1.99M	–	4121
2015 Q3	$1.99M	Buy	+96,192	New	+$1.97M	﹤0.01%	1907

Other funds holding NDRM

VOAM

Vertex One Asset Management Vancouver, British Columbia, Canada $434M AUM 37.82% 1-Year Est. Return

OTC

Opera Trading Capital Paris, France $419M AUM 0.58% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

FWM

Focused Wealth Management Newburgh, New York $964M AUM 18.71% 1-Year Est. Return

Millennium Management's NDRM Position: Q4 2017 in Review

Millennium Management sold out of NeuroDerm Ltd. Ordinary Shares (NDRM) in Q4 2017, closing a stake of 15,000 shares — an estimated $584K sold.

Millennium Management first reported a position in NDRM in Q3 2015 and held it in 5 quarters. The position peaked at $9.33M in Q4 2016. 5 funds tracked by Wall St. Rank hold NDRM as of Q4 2017.

Millennium Management reported no remaining NeuroDerm Ltd. Ordinary Shares position as of Q4 2017 after selling out during the quarter.
Millennium Management sold 15,000 NeuroDerm Ltd. Ordinary Shares shares in Q4 2017, an estimated $584K.
Millennium Management first reported a position in NeuroDerm Ltd. Ordinary Shares in Q3 2015 and held it in 5 quarters.
Millennium Management's NeuroDerm Ltd. Ordinary Shares position peaked at $9.33M in Q4 2016.
5 funds tracked by Wall St. Rank held NeuroDerm Ltd. Ordinary Shares as of Q4 2017.

Based on Millennium Management's 13F filing for Q4 2017, filed 14 Feb 2018.